Is ELAB Worth Buying in 2026?

PMGC Holdings Inc. Common Stock

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-04-19

Here’s whether PMGC Holdings Inc. Common Stock (ELAB) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: RSI 53 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-33.64% over 10 days); weak 1-year return of -98.5%; 3-month momentum negative (-82.8%). Currently 98.9% off its 52-week high. Score: -5/7.

Ready to act on this? 📈 Trade on Webull

ELAB is trading below its 200-day MA ($92.55) — a key warning sign the longer-term trend is under pressure. An RSI of 53.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -98.5% compares to +35.1% for SPY (trailed the market by 133.6%). The current 98.9% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $151 today
vs. S&P 500 (SPY) — same period trailed market by 133.6%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($92.55)
Above 50-day MA ($5.80)
RSI(14) neutral zone (30–70) — currently 53.0
Positive return (-98.5%)
!Within 10% of period high (−98.9%)
Period Range $3.28
$1.62 $309.12
RSI (14) 53.0
0 · OversoldOverbought · 100

Key Metrics

Price$3.28
Period Return-98.5%
Period High$309.12
Period Low$1.62
Drawdown−98.9%
MA-50$5.80
MA-200$92.55
RSI (14)53.0
Avg Volume (30d)14.8M
vs. SPYtrailed by 133.6%
Return Rank#987 of 996

Trade ELAB

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers